Publications by authors named "Greg Otterson"

Claim this Profile
R
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.
Martin J Edelman, Ming T Tan, Mary J Fidler, Rachel E Sanborn, Greg Otterson

J Clin Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancer.
Barbara J Gitlitz, Eric Bernstein, Edgardo S Santos, Greg A Otterson, Ginger Milne

J Thorac Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors.
J Paul Monk, Miguel Villalona-Calero, Joe Larkin, Greg Otterson, David S Spriggs

Invest New Drugs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis